This biphasic regulation of GDF15 expression was also observed in another study, which demonstrated a higher level of GDF15 mRNA in prostate cancer than in benign prostate tissues but a lower level of GDF15 mRNA in moderately and poorly differentiated adenocarcinomas than in well-differentiated prostate cancer [61]. This evidence concerns the gene GDF15 and adenocarcinoma.